Application no. and date | 10798728.1 (espacenet) (Federated) (European Patent Register), 20101210 | Patent/reg. no. and date | DK/EP 2513146, 20170503 | Publication date | 20121024 | Priority no. and date | GB 0922143, 20091218, GB 201009307, 20100603, GB 1009307, 20100603 | EP pub. no. and date |
EP 2513146 20121024 | Effective date | | Applicant/owner | Kancera AB, Karolinska Science Park Banvaktsvägen 22
171 48 Solna, SE | Applicant ref. no. | P41204548EP00 | Inventor | MELLSTEDT, HÃ¥kan, Nybrogatan 45 B
Stockholm 114 39, SE, RABBANI, Hodjattallah, Midskeppsgatan 1 5 tr
120 79 Stockholm, SE, TEIGE, Ingrid, Raketgatan 6
244 57 Lund, SE | Representative | Novitas Patent AB, P.O. Box 55557
102 04 Stockholm, SE | Opponent | | IPC Class | C07K 16/28 (2006.01) | Title | ANTISTOFFER MOD ROR1, DER ER I STAND TIL AT FREMKALDE CELLEDØD AF CLL | Int. application no. | EP2010007524 | Int. publication no. | WO2011079902 | Related patent (certificate) | | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|